HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antroquinonol from ethanolic extract of mycelium of Antrodia cinnamomea protects hepatic cells from ethanol-induced oxidative stress through Nrf-2 activation.

AbstractAIM OF THE STUDY:
In recent years, the medicinal mushroom Antrodia cinnamomea, known as "niu-chang chih" has received much attention with regard to its possible health benefits; especially its hepatoprotective effects against various drugs, toxins, and alcohol induced liver diseases. However, the molecular mechanism underlying this protective effect of Antrodia cinnamomea and its active compound antroquinonol was poorly understood. In the present study we evaluated to understand the hepatoprotective efficacy of antroquinonol and ethanolic extracts of mycelia of Antrodia cinnamomea (EMAC) in vitro and in vivo.
MATERIALS AND METHODS:
The protective mechanism of antroquinonol and EMAC against ethanol-induced oxidative stress was investigated in cultured human hepatoma HepG2 cells and ICR mice model, respectively. HepG2 cells were pretreated with antroquinonol (1-20μM) and oxidative stress was induced by ethanol (100mM). Meanwhile, male ICR mice were pretreated with EMAC for 10 days and hepatotoxicity was generated by the addition of ethanol (5g/kg). Hepatic enzymes, cytokines and chemokines were determined using commercially available assay kits. Western blotting and real-time PCR were subjected to analyze HO-1 and Nr-2 expression. EMSA was performed to monitor Nrf-2 ARE binding activity. Possible changes in hepatic lesion were observed using histopathological analysis.
RESULTS:
Antroquinonol pretreatment significantly inhibited ethanol-induced AST, ALT, ROS, NO, MDA production and GSH depletion in HepG2 cells. Western blot and RT-PCR analysis showed that antroquinonol enhanced Nrf-2 activation and its downstream antioxidant gene HO-1 via MAPK pathway. This mechanism was then confirmed in vivo in an acute ethanol intoxicated mouse model: serum ALT and AST production, hepatocellular lipid peroxidation and GSH depletion was prevented by EMAC in a dose-dependent manner. EMAC significantly enhanced HO-1 and Nrf-2 activation via MAPKs consistent with in vitro studies. Ethanol-induced hepatic swelling and hydropic degeneration of hepatocytes was significantly inhibited by EMAC in a dose-dependent manner.
CONCLUSIONS:
These results provide a scientific basis for the hepatoprotective effects of Antrodia cinnamomea. Data also imply that antroquinonol, a potent bioactive compound may be responsible for the hepatoprotective activity of Antrodia cinnamomea. Moreover, the present study highly supported our traditional knowledge that Antrodia cinnamomea as a potential candidate for the treatment of alcoholic liver diseases.
AuthorsK J Senthil Kumar, Fang-Hua Chu, Han-Wen Hsieh, Jiunn-Wang Liao, Wen-Hsiung Li, Johnson Chin-Chung Lin, Jei-Fu Shaw, Sheng-Yang Wang
JournalJournal of ethnopharmacology (J Ethnopharmacol) Vol. 136 Issue 1 Pg. 168-77 (Jun 14 2011) ISSN: 1872-7573 [Electronic] Ireland
PMID21540101 (Publication Type: Journal Article)
CopyrightCopyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Antioxidants
  • Biological Products
  • NF-E2-Related Factor 2
  • Reactive Oxygen Species
  • Ubiquinone
  • Nitric Oxide
  • Ethanol
  • Malondialdehyde
  • antroquinonol
  • HMOX1 protein, human
  • Heme Oxygenase-1
  • Transaminases
  • Mitogen-Activated Protein Kinases
  • Glutathione
Topics
  • Animals
  • Antioxidants (metabolism, pharmacology, therapeutic use)
  • Antrodia (chemistry)
  • Biological Products (pharmacology, therapeutic use)
  • Chemical and Drug Induced Liver Injury (drug therapy, metabolism)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Ethanol (adverse effects)
  • Glutathione (metabolism)
  • Heme Oxygenase-1 (metabolism)
  • Hep G2 Cells
  • Hepatocytes (drug effects, metabolism)
  • Humans
  • Lipid Peroxidation (drug effects)
  • Male
  • Malondialdehyde (metabolism)
  • Mice
  • Mice, Inbred ICR
  • Mitogen-Activated Protein Kinases (metabolism)
  • Mycelium
  • NF-E2-Related Factor 2 (metabolism)
  • Nitric Oxide (metabolism)
  • Oxidative Stress (drug effects)
  • Phytotherapy
  • Reactive Oxygen Species (metabolism)
  • Transaminases (metabolism)
  • Ubiquinone (analogs & derivatives, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: